On March 11, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and the fourth COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the […]

On 9 March, MEPs adopted the EU4Health programme for 2021-2027, which aims to prepare EU health systems more rigorously for future health threats and pandemics. The European Parliament endorsed the provisional agreement reached with the Council with 631 votes in favour, 32 against and 34 abstentions. The new EU4Health programme will contribute in areas where […]

The Coalition for Vaccination, convened by the European Commission, brings together European associations of healthcare professionals and relevant students’ associations in the field, as well as associated professional organisations working in the field of public health and immunisation. “We underline three key reasons why all healthcare professionals should get vaccinated against COVID-19 when they have […]

The Commission is setting out the main elements of the future Health Emergency Response Authority (HERA), to be proposed by the end of 2021. Such a structure would be an important new element to support a better EU level response to cross-border health threats. The roadmap is currently open for stakeholders to contribute with their […]

The Commission set out a number of actions needed to step up the fight against the pandemic. In a communication adopted on 19 January 2021, the Commission called on EU member states to accelerate the roll-out of vaccination across the EU: by March 2021, at least 80% of people over the age of 80, and […]

Today, on the eve of the World Cancer Day, the European Commission is presenting Europe’s Beating Cancer Plan – a main priority in the area of health of the von der Leyen Commission and a key pillar of a strong European Health Union. With new technologies, research and innovation as the starting point, the Cancer Plan sets out a new […]

Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by BioNTech and Pfizer, making it the first COVID-19 vaccine authorised in the EU. This authorisation follows a positive scientific recommendation based on a thorough assessment of the safety, effectiveness and quality of the vaccine by the European Medicines […]

On 15 December 2020, the Commission approved the political agreement between the Parliament and the Council to secure a health budget. EU4Health is the fourth and largest of the EU Health Programmes since their inception in 2003, with a dedicated budget of €5.1 billion allocated to it under the agreement by the European Parliament and Council […]

On December 11, UEMO was featured in a public meeting held by the European Medicines Agency (EMA), represented by Tiago Villanueva, who expressed its views on the rush for a COVID-19 vaccine and its implications for patients. The meeting came two days after the EMA suffered a cyber attack involving incognito access to the regulatory submission for […]